Who
Loic A. Vincent
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Korro Bio.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $74K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Apr 2025
- Last trade
- 15 Jul 2026
- Last filed
- 17 Jul 2026
Companies traded
Activity over time
1 Jun – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jul 2026filed 17 Jul 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 16 Jun 2026filed 17 Jun 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Sold | $37K3,418 at $10.83 | filing |
| 16 Jun 2026filed 17 Jun 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Sold | $37K3,418 at $10.83 | filing |
| 2 Feb 2026filed 3 Feb 2026 | KRRO Korro Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 2 Feb 2026filed 3 Feb 2026 | KRRO Korro Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 15 Dec 2025filed 16 Dec 2025 | KRRO Korro BioBiotechnology | SEC FORM 4 Code A | —21,715 at $0.00 | filing |
| 1 Apr 2025filed 1 Apr 2025 | KRRO Korro Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
News
BioLineRx (NASDAQ:BLRX) and Korro Bio (NASDAQ:KRRO) Head to Head SurveyKRRO · dailypolitical.com · 14 Oct 2026Contrasting BioLineRx (NASDAQ:BLRX) & Korro Bio (NASDAQ:KRRO)KRRO · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name Loic A. Vincent; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.